Medicare Panel Endorses Vaccine for Prostate Cancer Patients
Provenge extends survival by about four months on average, costs $93,000 per individualContinue Reading
Provenge extends survival by about four months on average, costs $93,000 per individualContinue Reading
About 15,000 Medicare patients die a month because of adverse events, researchers sayContinue Reading
Most frequently left drugs include cough, allergy, asthma and skin meds, study findsContinue Reading
In Australia, rich and poor have roughly similar rates of cardiovascular woes, study findsContinue Reading
Fewer plans to choose from, slightly higher monthly premiums are main differencesContinue Reading
Many of those without coverage are middle-income people or chronically ill, CDC saysContinue Reading
U.S. health reform helps many, but more will benefit if states step up, lung association saysContinue Reading
Study finds wide variations in drug spending, risky prescriptions for Medicare patientsContinue Reading
Financial incentives influence treatment rates, study findsContinue Reading
More outbreaks feared as immunization rates for children in commercial health plans plummetContinue Reading
Equitable, universal dental care could help ease the disparity, researchers sayContinue Reading
White kids more likely to get medicine, see specialist, researchers findContinue Reading
Data is insufficient for identifying high-quality surgical facilities, researchers sayContinue Reading
Higher reimbursement would save money overall, with more kids vaccinated, researchers suggestContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.